Pay in 4 interest-free payments of $6.55 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Aardvark Therapeutics Sector: Oral gut-restricted bitter taste receptor agonists for hunger suppression HQ: San Diego, CA Year Founded: 2017 Origin Story: Aardvark Therapeutics was founded around a mechanistically distinct hypothesis: rather than suppressing appetite like GLP-1 drugs, the companys lead compound activates bitter taste receptors (TAS2Rs) confined to the gastrointestinal tract to trigger local release of satiety hormones, targeting hunger itself without systemic drug exposure
Understanding formulation beyond color Color tells you about B12 content
The preparation happens the night before, so there is zero effort when morning nausea makes cooking unappealing
Mol Aspects Med 2008
US$ 24.47
US$ 23.96
US$ 21.19
US$ 22.96
US$ 24.51
US$ 20.52
